Filing Details

Accession Number:
0001549084-22-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-26 19:20:45
Reporting Period:
2022-09-21
Accepted Time:
2022-09-26 19:20:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1549084 Ekso Bionics Holdings Inc. EKSO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201619 Steven Sherman C/O Ekso Bionics Holdings, Inc.
101 Glacier Point, Suite A
San Rafael CA 94901
Ceo & Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-21 15,599 $0.00 694,594 No 4 M Direct
Common Stock Disposition 2022-09-22 6,043 $1.75 688,551 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-09-21 15,599 $0.00 15,599 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
62,398 No 4 M Direct
Footnotes
  1. Represents shares sold by the Reporting Person on September 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the eighth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.
  2. The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.70 to $1.80, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.
  3. The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
  4. The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The eighth installment of RSUs vested on September 22, 2022 and were delivered to the Reporting Person upon settlement.